Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJensen, K.B.-
dc.contributor.authorChen, H.-
dc.contributor.authorMorris, K.N.-
dc.contributor.authorStephens, A.-
dc.contributor.authorGold, L.-
dc.descriptionPublication number US5763566 A Publication type Grant Application number US 08/433,585 Publication date Jun 9, 1998 Filing date May 3, 1995 Priority date Jun 11, 1990-
dc.description.abstractThis invention discloses high-affinity oligonucleotide ligands to complex tissue targets, specifically nucleic acid ligands having the ability to bind to complex tissue targets, and the methods for obtaining such ligands. Tissue targets comprise cells, subcellular components, aggregates or cells, collections of cells, and higher ordered structures. Specifically, nucleic acid ligands to red blood cells ghosts, glioblastomas, and lymphomas are described.-
dc.description.statementofresponsibilityInventors: Jensen Kirk, Chen Hang, Morris Kevin N., Stephens Andrew, Gold Larry. Assignee: NeXstar Pharmaceuticals, Inc. Agents: Swanson & Bratschun LLC-
dc.titleSystematic evolution of ligands by exponential enrichment: tissue SELEX-
dc.contributor.assigneeSwanson & Bratschun LLC-
dc.identifier.orcidJensen, K.B. [0000-0002-2084-1734]-
Appears in Collections:Aurora harvest 7
Molecular and Biomedical Science publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.